Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection

Published:2020-03 Issue:3 Volume:83 Page:233-237
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Lin Te-Fu,Wu Deng-Chyang,Tsay Feng-Woei,Tsai Kuo-Wang,Tsai Tzung-Jiun,Peng Nan-Jing,Kao Sung-Shuo,Chen Wen-Chi,Chen Yan-Hua,Hsu Ping-I

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference35 articles.

1. Helicobacter pylori infection and the risk of gastric malignancy.;Hsu;Am J Gastroenterol,2007

2. Helicobacter pylori infection.;Suerbaum;N Engl J Med,2002

3. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.;Gumurdulu;World J Gastroenterol,2004

4. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy.;De Francesco;J Antimicrob Chemother,2007

5. New concepts of resistance in the treatment of Helicobacter pylori infections.;Graham;Nat Clin Pract Gastroenterol Hepatol,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection;Microorganisms;2023-12-19

2. The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis;PeerJ;2023-03-30

3. Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial;American Journal of Gastroenterology;2023-03-20

4. Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial;CASP J INTERN MED;2023

5. Cut-off value of clarithromycin resistance in the treatment ofHelicobacter pyloriinfection: how low is low?;Gut;2022-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3